Pricing Log in Create free account

Capricor Therapeutics, Inc. (CAPR) vs PureTech Health PLC Sponsored ADR (PRTCY)

Capricor Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Capricor Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($424.0M and $422.7M). PureTech Health PLC Sponsored ADR grew revenue faster over the last twelve months: 28.5% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −199.4%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 13 metrics below, Capricor Therapeutics, Inc. leads on 7 and PureTech Health PLC Sponsored ADR on 6.

Valuation

Metric CAPR PRTCY Biotechnology median
P/E n/m n/m 8.50
P/S 17.45 n/m 9.71
P/B 1.58 n/m 2.13
Price to free cash flow 2.97 n/m 20.82
EV/EBITDA n/m 0.81 0.64
EV/Sales 7.41 (9.10) 9.21
Earnings yield (36.51%) (1.48%) (33.15%)
Free cash flow yield 33.68% 0.00% (25.50%)

Profitability

Metric CAPR PRTCY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (199.36%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.70%) 0.00% (56.36%)
Return on assets (51.53%) 0.00% (48.04%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR PRTCY Biotechnology median
Revenue growth (TTM) (11.55%) 28.48% 6.02%
EPS growth (last fiscal year) (96.52%) (2,277.05%) 30.26%
Revenue growth, 5-year CAGR 85.83% (16.92%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.35 6.59 4.72
Net debt to EBITDA 2.99 3.03 0.96

Dividend

Metric CAPR PRTCY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CAPR PRTCY Biotechnology median
Market cap 422.67m 424.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack